Together, these results indicate that AAA-1 could promote hepatic steatosis either by increasing lipogenesis, promoting fatty acid uptake, or decreasing triglyceride oxidation or efflux via very low density lipoprotein (VLDL) secretion [7]. This evidence concerns the gene NPSR1-AS1 and fatty liver disease.